Cargando…

Assessment of Association Between Venous Occlusion and Infection of Cardiac Implantable Electronic Devices

The increasing number of patients treated with cardiac implantable electronic devices (CIEDs) and indications for complex pacing requires system revisions. Currently, data on venous patency in repeat CIED surgery involving lead (re)placement or extraction are largely missing. This study aimed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keyser, Andreas, Jungbauer, Carsten, Rennert, Janine, Linnemann, Birgit, Schmid, Christof, Schopka, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Cardiac Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873966/ https://www.ncbi.nlm.nih.gov/pubmed/34362260 http://dx.doi.org/10.1177/00033197211038376

Ejemplares similares

Early-BYRD: alternative early pacing and defibrillation lead replacement avoiding venous puncture
por: Keyser, Andreas, et al.
Publicado: (2018)

Atypical pathogens associated with cardiac implantable electronic device infections
por: Kohli, Utkarsh, et al.
Publicado: (2021)

The long‐term outcomes of cardiac implantable electronic devices implanted via the femoral route
por: Griffiths, Samuel, et al.
Publicado: (2022)

Implantable Cardiac Electronic Devices in the Elderly Population
por: Lim, Wei-Yao, et al.
Publicado: (2019)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022)

iPhone 12 MagSafe technology and cardiac implantable devices: Assessment of the actual risk
por: Censi, Federica, et al.
Publicado: (2022)

Heart failure treatment in patients with cardiac implantable electronic devices: Opportunity for improvement
por: Salimian, Samaneh, et al.
Publicado: (2021)

Hypersensitivity Reactions to Components of Cardiac Implantable Electronic Devices and Their Treatment: A Systematic Review
por: Kealaher, Emma, et al.
Publicado: (2023)

B-Cell lymphoma at the site of pacemaker generator
por: Keyser, Andreas, et al.
Publicado: (2020)

Echocardiographic Guidance of the Novel WaveCrest Left Atrial Appendage Occlusion Device
por: Vainrib, Alan F., et al.
Publicado: (2018)

Reducing cardiac implantable electronic device–induced artefacts in cardiac magnetic resonance imaging
por: Vuorinen, Aino-Maija, et al.
Publicado: (2022)

Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown
por: Magnocavallo, Michele, et al.
Publicado: (2021)

Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change
por: Bhuva, A. N., et al.
Publicado: (2019)

Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial
por: Martinson, Melissa, et al.
Publicado: (2016)

The cost‐effectiveness of real‐time pulmonary artery pressure monitoring in heart failure patients: a European perspective
por: Cowie, Martin R., et al.
Publicado: (2017)

Evaluation of a novel mechanical compression device for hematoma prevention and wound cosmesis after CIED implantation
por: Rojas, Edward, et al.
Publicado: (2022)

Clinical evaluation of a small implantable cardiac monitor with a long sensing vector
por: Piorkowski, Christopher, et al.
Publicado: (2019)

The missing link: Unlocking the power of cardiac rhythm monitoring device based QT interval detection
por: Chu, Antony F., et al.
Publicado: (2022)

Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx
por: Ip, John, et al.
Publicado: (2020)

Percutaneous Left Atrial Appendage Occlusion: A View From the UK
por: Ding, Wern Yew, et al.
Publicado: (2020)

R-Wave Sensing in an Implantable Cardiac Monitor without ECG-Based Preimplant Mapping: Results from a Multicenter Clinical Trial
por: Krahn, Andrew D, et al.
Publicado: (2014)

Transvenous lead implantation via the accessory hemiazygos vein in superior vena cava occlusion
por: Waddingham, Peter H., et al.
Publicado: (2021)

Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature
por: Henkes, Hans, et al.
Publicado: (2019)

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

Optimizing atrio‐ventricular delay in pacemakers using potentially implantable physiological biomarkers
por: Keene, Daniel, et al.
Publicado: (2022)

Longevity decoded: Insights from power consumption analyses into device construction and their clinical implications
por: Lau, Ernest W.
Publicado: (2019)

Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study
por: Rosenberg, Michael A, et al.
Publicado: (2013)

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2014)

Clinical Pathways Guided by Remotely Monitoring Cardiac Device Data: The Future of Device Heart Failure Management?
por: Taylor, Joanne K, et al.
Publicado: (2023)

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
por: Broers, Eva R., et al.
Publicado: (2019)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Long‐term outcomes of cardiac resynchronization therapy in adult congenital heart disease
por: Leyva, Francisco, et al.
Publicado: (2019)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Cardiac resynchronization therapy with intraoperative epicardial mapping via minithoracotomy: 10 years’ experience
por: Hejjel, László, et al.
Publicado: (2020)

Improvement of Right Ventricular Hemodynamics with Left Ventricular Endocardial Pacing during Cardiac Resynchronization Therapy
por: HYDE, EOIN R., et al.
Publicado: (2016)

Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials
por: Coats, Andrew J.S., et al.
Publicado: (2022)

Device rounds: T-wave oversensing: A cause of loss of cardiac resynchronization therapy
por: Dayal, Nicolas B., et al.
Publicado: (2016)

Novelty about pocket histology at cardiac implantable electronic device reopening procedures
por: Massaro, G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uq2vfgqa4em2rtfm2h7aah5eu1